283 related articles for article (PubMed ID: 7083200)
21. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
Cohen MH; Johnson JR; Li N; Chen G; Pazdur R
Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893
[TBL] [Abstract][Full Text] [Related]
22. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
Miller WR; Stuart M; Sahmoud T; Dixon JM
Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
[TBL] [Abstract][Full Text] [Related]
23. Aromatase inhibitors in breast cancer therapy.
Brueggemeier RW
Expert Rev Anticancer Ther; 2002 Apr; 2(2):181-91. PubMed ID: 12113240
[TBL] [Abstract][Full Text] [Related]
24. Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
Wing LY; Garrett WM; Brodie AM
Cancer Res; 1985 Jun; 45(6):2425-8. PubMed ID: 3921242
[TBL] [Abstract][Full Text] [Related]
25. In vivo effects of delta 1-testololactone on peripheral aromatization.
Judd HL; Barone RM; Laufer LR; Gambone JC; Monfort SL; Lasley BL
Cancer Res; 1982 Aug; 42(8 Suppl):3345s-3348s. PubMed ID: 7083208
[TBL] [Abstract][Full Text] [Related]
26. Pharmacology of aminoglutethimide: structure/activity relationships and receptor interactions.
Nicholls PJ; Daly MJ; Smith HJ
Breast Cancer Res Treat; 1986; 7 Suppl():S55-67. PubMed ID: 3755630
[TBL] [Abstract][Full Text] [Related]
27. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
[TBL] [Abstract][Full Text] [Related]
28. Aromatase inhibitors in metastatic breast cancer.
Buzdar AU; Plourde PV; Hortobagyi GN
Semin Oncol; 1996 Aug; 23(4 Suppl 9):28-32. PubMed ID: 8824462
[TBL] [Abstract][Full Text] [Related]
29. Aromatase inhibitors: rationale for use following antiestrogen therapy.
Yue W; Santen RJ
Semin Oncol; 1996 Aug; 23(4 Suppl 9):21-7. PubMed ID: 8824461
[TBL] [Abstract][Full Text] [Related]
30. Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide.
Bezwoda WR; Mansoor N; Dansey R
Oncology; 1987; 44(6):345-9. PubMed ID: 3684175
[TBL] [Abstract][Full Text] [Related]
31. Basic studies on aminoglutethimide.
Salhanick HA
Cancer Res; 1982 Aug; 42(8 Suppl):3315s-3321s. PubMed ID: 7083193
[TBL] [Abstract][Full Text] [Related]
32. Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.
Santen RJ
Breast Cancer Res Treat; 1981; 1(3):183-202. PubMed ID: 6293627
[TBL] [Abstract][Full Text] [Related]
33. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
Sterns EE; Bird CE; Mackie KW
Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430
[TBL] [Abstract][Full Text] [Related]
34. [Aromatase inhibitor].
Stein M
Med Monatsschr Pharm; 1993 Mar; 16(3):66-7. PubMed ID: 8464387
[No Abstract] [Full Text] [Related]
35. Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.
Dowsett M; Santner SJ; Santen RJ; Jeffcoate SL; Smith IE
Br J Cancer; 1985 Jul; 52(1):31-5. PubMed ID: 4015950
[TBL] [Abstract][Full Text] [Related]
36. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
37. Clinical studies with aminoglutethimide in advanced breast carcinoma.
Harvey HA; Lipton A; Santen RJ
Acta Clin Belg Suppl; 1986; 11():29-40. PubMed ID: 3459321
[No Abstract] [Full Text] [Related]
38. Endocrine effects of low dose aminoglutethimide with hydrocortisone--an optimal hormone suppressive regimen.
Harris AL; Dowsett M; Cantwell BM; Sainsbury JR; Needham G; Farndon J; Wilson R
Breast Cancer Res Treat; 1986; 7 Suppl():S69-72. PubMed ID: 2943338
[TBL] [Abstract][Full Text] [Related]
39. Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.
Lønning PE; Dowsett M; Powles TJ
J Steroid Biochem; 1990 Mar; 35(3-4):355-66. PubMed ID: 2139151
[TBL] [Abstract][Full Text] [Related]
40. Biological significance of aromatase activity in human breast tumors.
Tilson-Mallett N; Santner SJ; Feil PD; Santen RJ
J Clin Endocrinol Metab; 1983 Dec; 57(6):1125-8. PubMed ID: 6630410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]